cefaclor anhydrous has been researched along with Bronchitis, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhter, N; Anwer, N; Fareed, A; Ghori, RA; Imran, K; Iqbal, ZH; Javaid, A; Khan, MH; Khan, MK; Khan, S; Khan, SU; Mahmood, K; Rahman, F; Siddqui, SJ; Ullah, S | 1 |
| Chyczewska, E; Grzelewska-Rzymowska, I; Haczyński, J; Malolepszy, J; Marcinkowska-Suchowierska, E; Milanowski, J; Oklek, K; Płusa, T; Rek, M; Szmygin, K; Słominski, J | 1 |
2 trial(s) available for cefaclor anhydrous and Bronchitis, Chronic
| Article | Year |
|---|---|
Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG).
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis, Chronic; Cefaclor; Clarithromycin; Female; Humans; Male; Middle Aged; Single-Blind Method; Treatment Outcome | 2003 |
Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis, Chronic; Cefaclor; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Single-Blind Method; Time Factors; Treatment Outcome | 2002 |